Cancer Genetic Testing
Cross-source consensus on Cancer Genetic Testing from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Benefits
Risks & contraindications
Evidence quality
Highlighted claims
- Germline genetic testing can identify pathogenic variant carriers and enable earlier screening, prevention, and targeted therapy access. — Does financial subsidy equalise cancer genetic testing uptake across socioeconomic groups? A retrospective observational study in Singapore
- A single cancer genetic test in Singapore costs around SGD 1,000, and there are no government subsidies for testing costs. — Does financial subsidy equalise cancer genetic testing uptake across socioeconomic groups? A retrospective observational study in Singapore
- Overall, 70% of the analytical sample consented to testing after pretest counselling. — Does financial subsidy equalise cancer genetic testing uptake across socioeconomic groups? A retrospective observational study in Singapore
- Testing was recommended for hereditary breast and ovarian cancer, Lynch syndrome, known familial pathogenic variants, and universal tumour screening contexts. — Does financial subsidy equalise cancer genetic testing uptake across socioeconomic groups? A retrospective observational study in Singapore
- Clinical genetic testing uptake remains limited worldwide despite its benefits. — Does financial subsidy equalise cancer genetic testing uptake across socioeconomic groups? A retrospective observational study in Singapore